G1 Therapeutics, Inc.
Pharmaceutical company · Research Triangle Park, North Carolina, United States
G1 Therapeutics, Inc. is a pharmaceutical company headquartered in Research Triangle Park, North Carolina, United States. Its earliest recorded incorporation is in 2008. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $5 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2016.
G1 Therapeutics at a glance
What does G1 Therapeutics do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $5 million in total (2009 to 2014).
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $50 million sold (2016).
Frequently asked questions about G1 Therapeutics
Where is G1 Therapeutics headquartered?
G1 Therapeutics, Inc. is headquartered in Research Triangle Park, North Carolina, United States.
What does G1 Therapeutics do?
G1 Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was G1 Therapeutics founded?
The earliest incorporation on record for G1 Therapeutics, Inc. is in 2008, according to public company registers.
Similar companies
- Opus Genetics, Inc.Durham, North Carolina, United States
- Polarean, Inc.Durham, North Carolina, United States
- T3D Therapeutics, Inc.Durham, North Carolina, United States
- Chimerix IncDurham, North Carolina, United States
- LadeRx, LLCDurham, North Carolina, United States
- BioMarck Pharmaceuticals LtdDurham, North Carolina, United States
- Satsuma Pharmaceuticals, Inc.Durham, North Carolina, United States
- Tellus Therapeutics, Inc.Durham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences